These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models. Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413 [No Abstract] [Full Text] [Related]
3. A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells. Kanai R; Wakimoto H; Martuza RL; Rabkin SD Clin Cancer Res; 2011 Jun; 17(11):3686-96. PubMed ID: 21505062 [TBL] [Abstract][Full Text] [Related]
4. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma. Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211 [TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts. Cheema TA; Kanai R; Kim GW; Wakimoto H; Passer B; Rabkin SD; Martuza RL Clin Cancer Res; 2011 Dec; 17(23):7383-93. PubMed ID: 21976549 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus. Jahan N; Lee JM; Shah K; Wakimoto H Int J Cancer; 2017 Oct; 141(8):1671-1681. PubMed ID: 28567859 [TBL] [Abstract][Full Text] [Related]
7. Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy. Duebgen M; Martinez-Quintanilla J; Tamura K; Hingtgen S; Redjal N; Wakimoto H; Shah K J Natl Cancer Inst; 2014 Jun; 106(6):dju090. PubMed ID: 24838834 [TBL] [Abstract][Full Text] [Related]
15. The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment. Meisen WH; Wohleb ES; Jaime-Ramirez AC; Bolyard C; Yoo JY; Russell L; Hardcastle J; Dubin S; Muili K; Yu J; Caligiuri M; Godbout J; Kaur B Clin Cancer Res; 2015 Jul; 21(14):3274-85. PubMed ID: 25829396 [TBL] [Abstract][Full Text] [Related]
16. TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response. Han J; Chen X; Chu J; Xu B; Meisen WH; Chen L; Zhang L; Zhang J; He X; Wang QE; Chiocca EA; Kaur B; Caligiuri MA; Yu J Cancer Res; 2015 Dec; 75(24):5273-82. PubMed ID: 26631269 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate. Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF mBio; 2018 Sep; 9(5):. PubMed ID: 30228241 [TBL] [Abstract][Full Text] [Related]
18. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma. Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998 [TBL] [Abstract][Full Text] [Related]
19. Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models. Zhang W; Fulci G; Wakimoto H; Cheema TA; Buhrman JS; Jeyaretna DS; Stemmer Rachamimov AO; Rabkin SD; Martuza RL Neoplasia; 2013 Jun; 15(6):591-9. PubMed ID: 23730207 [TBL] [Abstract][Full Text] [Related]